skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi team,
I was wondering if you could briefly describe the business model of eglx. I realize it’s a gaming platform , but how do they make money, and what are their plans for long term growth? On a separate note I am a little confused as to why eglx is being compared to scr? From what I gather scr is pretty much solely online sports betting now , and eglx is gaming? Also, would eglx be one to buy right now? And how bullish are you on the name? Is it a potential multi bagger ? Thanks
Shane
Read Answer Asked by Shane on April 30, 2021
Q: I am up 72% on TFII in my TFSA account, the total value of this holding represents ~2% of my portfolio. The funds in my TFSA are targeted for growth and I have no immediate need for the cash so I can take on reasonable risk for greater reward with a longterm view. Should I sell my holding to realize the capital gain or hold? If you suggest selling what would you suggest as a replacement?
Read Answer Asked by Simon on April 30, 2021
Q: i took a loss on FSZ last year but with recent results and my transition into retirement i wanted to get your views on the Dividend. As other members have commented it has not increased its dividend since 2019 but is the current dividend sustainable? The results seemed good and for a retiree it is very difficult to find this kind of yield?

Thanks
Read Answer Asked by kelly on April 29, 2021
Q: Hi 5i team,

Was looking at the Kinaxis Company Profile page on your web site in anticipation of KXS upcoming earnings report on May 5.
There is a huge divergence in the Q1, Q2, FY1 and FY2 wrt the 90/60 vs the 30, 7 and Current consensus EPS estimates.
Can you please explain the reason for the divergence? Was this simply due to their lowered guidance after their last Q release?
It seems like this is setting up for some major disappointment ahead wrt EPS changes.
Is this already reflected in the current stock price?
What is Kinaxis track record for meeting/beating guidance?
I assume the stock is a hold until on or after May 5 and perhaps buy into any weakness in anticipation of some new meaningful contracts in 2021?

Cheers,
Steve
Read Answer Asked by Stephen on April 28, 2021
Q: I was interested in Jeff's follow-up comment on Excelon sales declining. Who sold it before Knight in Latam and Canada? Perhaps the reason the company made a deal with Knight is to improve visibility and awareness while giving Knight's sales force new avenues for it's other products.
The price tag does not appear to be a bargain (Knight paid $360M or double for $250M sales in Biotoscan). Surely Goodman sees value in this deal. If there was no effort before then potential must be factored in and I suspect Latam is the more coveted marketplace. Can you comment and provide any previous history with sales of this product. Alzheimers us unfortunately, not going anywhere soon.
Read Answer Asked by Steven on April 27, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!